including cells that secrete the hormones somatostatin, ghrelin, and pancreatic polypeptide Y. They have also discovered that the secretion of each of these hormones depends on specific factors.

Tirzepatide, a dual agonist of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, represents a novel therapeutic option for both glycemic control and ...